Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1981 1
1991 5
1992 2
1994 1
1995 2
1997 1
1998 1
1999 3
2004 1
2009 2
2010 2
2011 2
2012 4
2013 4
2014 2
2015 2
2016 3
2017 3
2018 1
2019 1
2020 6
2021 6
2022 5
2023 8
2024 10
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N, Grinyó JM, Colom H, Vidal-Alabró A, Fontova P, Rigo-Bonnin R, Padró A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Favà A, Torras J, Cruzado JM. Lloberas N, et al. Among authors: coloma a. Kidney Int. 2023 Oct;104(4):840-850. doi: 10.1016/j.kint.2023.06.021. Epub 2023 Jun 28. Kidney Int. 2023. PMID: 37391040 Free article. Clinical Trial.
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.
Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators. Barratt J, et al. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15. Clin J Am Soc Nephrol. 2024. PMID: 38214599 Free PMC article. Clinical Trial.
Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis.
Oliveras L, Coloma A, Lloberas N, Lino L, Favà A, Manonelles A, Codina S, Couceiro C, Melilli E, Sharif A, Hecking M, Guthoff M, Cruzado JM, Pascual J, Montero N. Oliveras L, et al. Among authors: coloma a. Transplant Rev (Orlando). 2024 Jul;38(3):100856. doi: 10.1016/j.trre.2024.100856. Epub 2024 May 1. Transplant Rev (Orlando). 2024. PMID: 38723582
Blood Gene Expression Profiling and Donor-derived Cell-free DNA to Noninvasively Diagnose Clinical and Subclinical Kidney Transplant Rejection: A Real-life Appraisal Study.
Sellarés J, Casanova F, Perez-Saez MJ, Cucchiari D, Coloma A, Vila A, Facundo C, Kervella D, Molina M, Moreso F, Melilli E, Diekmann F, Crespo M, Bestard O. Sellarés J, et al. Among authors: coloma a. Transplantation. 2025 Jun 1;109(6):1026-1037. doi: 10.1097/TP.0000000000005257. Epub 2024 Nov 18. Transplantation. 2025. PMID: 40020163
Therapeutic Agents from Endophytes.
Kaushik N, Coloma AG. Kaushik N, et al. Among authors: coloma ag. Curr Med Chem. 2020;27(11):1813-1814. doi: 10.2174/092986732711200423115020. Curr Med Chem. 2020. PMID: 32340601 No abstract available.
Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approach.
Fernández-Alarcón B, Nolberger O, Vidal-Alabró A, Rigo-Bonnin R, Grinyó JM, Melilli E, Montero N, Manonelles A, Coloma A, Favà A, Codina S, Cruzado JM, Colom H, Lloberas N. Fernández-Alarcón B, et al. Among authors: coloma a. Front Pharmacol. 2024 Sep 19;15:1456565. doi: 10.3389/fphar.2024.1456565. eCollection 2024. Front Pharmacol. 2024. PMID: 39364055 Free PMC article.
Randomized clinical trial of non-antibiotic prophylaxis with d-Mannose plus Proanthocyanidins vs. Proanthocyanidins alone for urinary tract infections and asymptomatic bacteriuria in de novo kidney transplant recipients: The Manotras study.
Rau M, Santelli A, Martí S, Díaz MI, Sabé N, Fiol M, Riera L, Etcheverry B, Codina S, Coloma A, Carreras-Salinas A, Ardanuy C, Cruzado JM, Melilli E. Rau M, et al. Among authors: coloma a. Nefrologia (Engl Ed). 2024 May-Jun;44(3):408-416. doi: 10.1016/j.nefroe.2024.02.011. Epub 2024 Apr 17. Nefrologia (Engl Ed). 2024. PMID: 38637262 Free article. Clinical Trial.
Clostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study.
Pujol M, Limón E, Sopena N, Lopez-Contreras J, Castellá L, Cuquet J, López-Sánchez M, Pérez R, Gudiol C, Coloma A, Marimón M, Espinach J, Andres M, Martos P, Hernández S, Almendral A, Saliba P, Rodrigues GC, Calbo E, Group VP. Pujol M, et al. Among authors: coloma a. Future Microbiol. 2022 Dec;17:1445-1453. doi: 10.2217/fmb-2022-0076. Epub 2022 Oct 31. Future Microbiol. 2022. PMID: 36314417
Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study.
Aranda J, Oriol I, Feria L, Abelenda G, Rombauts A, Simonetti AF, Catalano C, Pallarès N, Martín M, Vàzquez N, Vall-Llosera E, Rhyman N, Suárez RC, Nogué M, Loureiro-Amigo J, Coloma A, Ceresuela L, Carratalà J. Aranda J, et al. Among authors: coloma a. PLoS One. 2022 Oct 10;17(10):e0275615. doi: 10.1371/journal.pone.0275615. eCollection 2022. PLoS One. 2022. PMID: 36215250 Free PMC article.
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
Fontova P, Colom H, Rigo-Bonnin R, Bestard O, Vidal-Alabró A, van Merendonk LN, Cerezo G, Polo C, Montero N, Melilli E, Manonelles A, Meneghini M, Coloma A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Fontova P, et al. Among authors: coloma a. Clin Pharmacol Ther. 2021 Jul;110(1):238-247. doi: 10.1002/cpt.2220. Epub 2021 Mar 25. Clin Pharmacol Ther. 2021. PMID: 33626199 Free article. Clinical Trial.
77 results